PENTAX Medical launches the C2 CryoBalloon(TM) Ablation System in Canada for the treatment of Barrett’s Esophagus.
MISSISSAUGA, ON, Oct. 15, 2022 /PRNewswire/ -- PENTAX Medical, a healthcare industry leader in diagnostic and therapeutic endoscopy solutions, announced today the Canadian launch of the C2 CryoBalloon™ Ablation System for the treatment of Barrett's Esophagus. "With the launch of C2 CryoBalloon Ablation System, there is now a new and effective way to treat Barrett's Esophagus in Canada", says...
China Matters’ Feature: How is Dongguan changing manufacturing with 3D printing?
BEIJING, Oct. 14, 2022 /PRNewswire/ -- Dongguan has long been known as the "factory of the world." The city has produced one third of the world's accessories and daily goods, and one out of six phones in the world is made from here. But over the recent years, the city...
Parexel Recognized by Frost & Sullivan with 2022 Global Customer Value Leadership Award
The award recognizes Parexel for delivering the best decentralized trial experience for customers through its capabilities, expertise, and patient recruitment and retention strategies SAN ANTONIO, Oct. 14, 2022 /PRNewswire/ -- Based on its recent analysis of the global decentralized clinical trials (DCT) industry, Frost & Sullivan has recognized leading global clinical research organization...
Tianfu International Biocity: Build Global Bioindustry-city
CHENGDU, China, Oct. 14, 2022 /PRNewswire/ -- On Oct.10, Chengdu Tianfu Global International Biocity saw the signing of ten project agreements totalling nearly 9B CNY in value and covering modern biopharmaceuticals, innovative chemical drugs, sophisticated medical apparatuses and other important fields. Geneseeq, a Chinese genetic disease testing giant, intends to invest in a local facility and industrialization base of genetic...
2022 Tang Prize Masters’ Forum Series Sheds Light on Current Global Challenges
TAIPEI, Oct. 14, 2022 /PRNewswire/ -- Established by Dr. Samuel Yin in 2012, the Tang Prize celebrates its 10th anniversary this year with the 2022 Tang Prize Masters' Forum series that came to a successful conclusion in September. Six 2022 laureates, Professor Jeffrey Sachs for Sustainable Development, Drs. Katalin Kariko, Drew Weissman, Pieter Cullis for Biopharmaceutical Science, Professor Dame...
StarHub Launches Digital Health Service with Alexandra Hospital and ConnectedLife with Fitbit to Connect Patients with Doctors, Health Coaches and Caregivers
Personalised health and lifestyle app which integrates consenting users' Fitbit data First health tracking app that links a patient to a family doctor or General Practitioner (GP), health coach and caregiver to better manage pre- and non-complex chronic conditions Alexandra Hospital is the first hospital to onboard the new service and it is helping to connect the...
WuXi Biologics Receives “Best CDMO Award of the Year”
SHANGHAI, Oct. 14, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has received the "Best CDMO Award of the Year" at the Asia-Pacific Biologics CMO Excellence Awards (APBCEA) 2022 hosted by IMAPAC. Over the years since 2017, WuXi Biologics has received multiple awards in various categories...
Fosun Pharma’s MSCI ESG Rating Upgraded to A
SHANGHAI, Oct. 14, 2022 /PRNewswire/ -- The world's leading index company Morgan Stanley Capital International ("MSCI") recently announced its latest annual Environmental, Social and Governance ("ESG") rating results. In recognition of its outstanding performance in ESG, MSCI upgraded the ESG rating of Fosun Pharma (stock code: 600196.SH, 02196.HK) from BBB to A, ranking the top level in China. Fosun...
Health Canada Approves Illuccix® for Prostate Cancer Imaging
MELBOURNE, Australia, Oct. 14, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces that Health Canada has approved Illuccix® for use in staging and re-staging intermediate and high-risk prostate cancer and localizing tumour tissue in recurrent prostate cancer. Illuccix™ , after radiolabeling with gallium (68Ga), is indicated for use with...
Transcenta to Present Two Scientific Posters at SITC 2022 Annual Meeting
SUZHOU, China, Oct. 14, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that it will present two scientific posters at the 37th Society for Immunotherapy of Cancer's (SITC) Annual Meeting in Boston, MA, November 8-12, 2022: one related to Claudin18.2...
